/0Q8D7J(6X@B03X@)(1).png)
On May 10, 2016, Medidata, the world's leading provider of cloud solutions for life sciences clinical research, announced the acquisition of Intelemage, the world's leading medical image sharing and process management platform. Medidata integrates Intelemage technology with its industry-leading software-as-a-service (SaaS) platform, Medidata Clinical Cloud, to provide customers with end-to-end solutions for capturing, managing and analyzing medical imaging data, the largest and most growing healthcare sector. A fast data source. The transaction was completed in the second quarter of 2016.
Founded in 2007, Intelemage has been dedicated to the sharing of medical image files, assisting clinical trials, serving major hospitals, doctors, life science companies, research institutions and core laboratories. The company also provides the tools needed for medical image data collection and process management. Intelemage is currently operating in more than 5,000 locations in 85 countries and around the world. Its technology ensures that customers can manage all medical imaging activities in a single environment, enabling customers to maximize control and access to data, performance metrics, and other clinical resources. Intelemage has processed 400 million medical images in the past 12 months.
Mr. Tarek Sherif, CEO of Medidata, said: “Medical imaging technology plays a vital role in evaluating new therapies, allowing clinicians and sponsors to detect disease, monitor results and predict treatment response. Integrating Intelemage technology will further strengthen Medidata Clinical Cloud's position as a benchmark in the industry. We are pleased to add a new generation of medical imaging capabilities to this fast-growing market, combined with the strength of the Medidata Cloud Platform to improve the design, speed, efficiency and analytical rigor of clinical trials, helping Patients get innovative treatments faster."
Intelemage's customers include 14 of the world's top 15 medical device companies. Through the acquisition of Intelemage, Medidata will further strengthen its capabilities as the leading cloud technology platform in the life sciences. Medidata Technology is committed to transforming the design and implementation of clinical trials and has supported more than 11,000 clinical studies, 400,000 research centers and 2.8 million clinical volunteers. Nichollas Wharton, co-founder and senior vice president of Intel Meage's customer and partner Medical Metrics, said: "Intelemage's medical imaging technology enables us to seamlessly collect data, streamline processes, and deliver in a safe, reliable and regulatoryly compliant manner. Medical Imaging Data More and more clinicians and sponsors are turning to medical imaging-based biomarkers to detect and monitor disease and assess the effectiveness of treatment. We are pleased to see Intelemage join Medidata. Medidata Cloud Platform is committed to transforming clinical research With Intelemage's cutting-edge technology in global medical image sharing and management, I believe that the Medidata Cloud Platform will play a more important role in driving medical innovation and improving the quality of life of patients around the world.†Medical Metrics as a medical imaging core Leading supplier of laboratories serving global clinical trials of medical devices, pharmaceuticals and biopharmaceuticals in the plastic surgery, cardiovascular and neurovascular fields. The company has been a customer and partner of Intelemage since 2013.
Disposable Cardiovascular Pack
Cardiovascular Pack,Surgical Cardiovascular Pack,Disposable Cardiovascular Pack,Disposable Sterile Cardiovascular Pack
Xinxiang Huaxi Sanitary Materials Co., Ltd. , https://www.huaximedical.com